Historique
![Assessing New Zealand's Cannabis Legalization and Control Bill: prospects and challenges [Addiction Opinion and Debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_83717.webp?v=1771252938)
BACKGROUND: Few countries have developed detailed legislative proposals for legalizing cannabis. New Zealand recently released the Cannabis Legalization and Control Bill (CLCB) that will be the subject of a referendum in September 2020.
AIMS: [...]
Auteur M. RYCHERT
10 Documents disponibles écrits par cet auteur
R. VAN DER SANDEN ; C. WILKINS ; M. RYCHERT ; M. J. BARRATT | 2022
Dans International Journal of Drug Policy (Vol.108, October 2022) Article : PériodiqueSocial media is increasingly being utilized to facilitate the buying and selling of illegal drugs, particularly by young people. However, the range of social media and messaging platforms means people must make 'choices' around which platforms t[...]
Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]
R. VAN DER SANDEN ; C. WILKINS ; M. RYCHERT | 2024
Dans Drugs: Education, Prevention and Policy (Vol.31, n°3, June 2024) Article : PériodiqueBackground and Aim: Social media drug markets are likely to present people participating in these spaces with new vulnerabilities to law enforcement. There is currently limited research on how people perceive and manage the risk of exposure to l[...]
M. RYCHERT ; C. WILKINS | 2016
Dans International Journal of Drug Policy (Vol.37, November 2016) Article : PériodiqueBackground: The establishment of a regulated legal market for new psychoactive substances (NPS, 'legal highs') under New Zealand's Psychoactive Substances Act (PSA) 2013 created a new commercial sector for psychoactive products, previously limit[...]
M. RYCHERT ; C. WILKINS ; K. WITTEN | 2018
Dans Drugs: Education, Prevention and Policy (Vol.25, n°3, June 2018) Article : PériodiqueIntroduction: New Zealand's Psychoactive Substances Act (PSA) 2013 established the world's first regulated legal market for low risk psychoactive products. Aim: To explore challenges in relation to regulating the retail environment and public c[...]
Differences in drug market conditions, for which data are often limited, can have important implications for the health and social harms of drug use and the related responses by relevant agencies in this field. A key component of monitoring illi[...]![Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries [Addiction Opinion and Debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_84391.webp?v=1771288420)
P. J. ADAMS ; M. RYCHERT ; C. WILKINS | 2021
Dans Addiction (Vol.116, n°11, November 2021) Article : PériodiqueBACKGROUND AND AIM: New Zealand has recently legalized medicinal cannabis and has explored the possibility of legalizing large-scale recreational cannabis supply. In the process, concerns have emerged regarding whether corporations involved in t[...]
R. VAN DER SANDEN ; C. WILKINS ; J. S. ROMEO ; M. RYCHERT ; M. J. BARRATT | 2021
Dans International Journal of Drug Policy (Vol.98, December 2021) Article : PériodiqueBackground: There are increasing reports of social media being used to buy and sell illegal drugs internationally. Studies of social media drug markets to date have largely involved general explorations of social media drug transactions in selec[...]
M. RYCHERT ; C. WILKINS | 2016
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : PériodiqueThe problem of defining what psychoactive products and substances should be covered by legislation aimed at controlling new psychoactive substances (NPS; 'legal highs') is central to the current debate on designing new legislative responses to N[...]
